Cohort study on the safety and efficacy of laparoscopic surgical robot, Revo-i(MSR-5100)

A single-center prospective, cohort study on the safety and efficacy of laparoscopic surgical robot, Revo-i(MSR-5100)

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0004323

Enrollment

Registered

2019-10-15

Start date

2019-12-30

Completion date

Unknown

Last updated

2022-11-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Procedure/Surgery : 1) Those who visit the outpatient and deem it necessary to treat the target disease will be referred to this clinical. 2) Those who voluntarily sign the consent form and satisfying

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Adults over 19 2) Voluntary consent to clinical research and be willing to comply with the protocol 3) A person who needs to have a resection for colon and rectal cancer -Histopathologically confirmed by adenocarcinoma of the rectum or colon -No remote metastasis (M0) -Primary tumor without other peripheral organ involvement (T1-T4a) -When intestinal obstruction is not accompanied -In case of elective surgery -Does not require resection of any organ other than the primary tumor 4) Others who have been diagnosed as having to receive a colon and rectal resection according to the researcher's judgment

Exclusion criteria

Exclusion criteria: 1) Have mental illness or serious systemic disease 2) Body Mass Index (BMI) = 30, high obesity 3) General anesthesia is not possible due to uncontrolled bleeding tendency or lowering of cardiopulmonary function 4) Have a positive pregnancy or be preparing for pregnancy 5) Wish to undergo conventional laparoscopy or da Vinci robotic surgery 6) Have a history of lower abdominal and pelvic laparotomy 7) Prone to bleeding 8) Older than 80 years old 9) In case of remote metastasis (M1) 10) Adjacent organ invasion (T4b) or require a resection of any organ other than the primary tumor 11) With intestinal obstruction, perforation, or emergency surgery

Design outcomes

Primary

Measure	Time frame
Success rate	—

Secondary

Measure	Time frame
Operative time;Intraoperative blood loss;Hospital day;Incidence of complication	—

Countries

Korea, Republic of

Contacts

Public ContactByung Soh Min

Yonsei University Health System, Severance Hospital

Outcome results